Cargando…

Selected Molecular Targets for Antiepileptogenesis

The term epileptogenesis defines the usually durable process of converting normal brain into an epileptic one. The resistance of a significant proportion of patients with epilepsy to the available pharmacotherapy prompted the concept of a causative treatment option consisting in stopping or modifyin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pawlik, Marek J., Miziak, Barbara, Walczak, Aleksandra, Konarzewska, Agnieszka, Chrościńska-Krawczyk, Magdalena, Albrecht, Jan, Czuczwar, Stanisław J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466306/ https://www.ncbi.nlm.nih.gov/pubmed/34575901 http://dx.doi.org/10.3390/ijms22189737

Ejemplares similares

Neurosteroids and Seizure Activity
por: Miziak, Barbara, et al.
Publicado: (2020)

Anti-Epileptogenic Effects of Antiepileptic Drugs
por: Miziak, Barbara, et al.
Publicado: (2020)

Some Candidate Drugs for Pharmacotherapy of Alzheimer’s Disease
por: Miziak, Barbara, et al.
Publicado: (2021)

Apitherapy in Post-Ischemic Brain Neurodegeneration of Alzheimer’s Disease Proteinopathy: Focus on Honey and Its Flavonoids and Phenolic Acids
por: Pluta, Ryszard, et al.
Publicado: (2023)

Post-Ischemic Permeability of the Blood–Brain Barrier to Amyloid and Platelets as a Factor in the Maturation of Alzheimer’s Disease-Type Brain Neurodegeneration
por: Pluta, Ryszard, et al.
Publicado: (2023)

Editorial: Epilepsy and endocrine function
por: Miziak, Barbara, et al.
Publicado: (2023)

Antiepileptogenesis and disease modification: Clinical and regulatory issues
por: French, Jacqueline A., et al.
Publicado: (2021)

Epilepsy in Pregnancy—Management Principles and Focus on Valproate
por: Błaszczyk, Barbara, et al.
Publicado: (2022)

Second Generation of Antiepileptic Drugs and Oxidative Stress
por: Kośmider, Kamil, et al.
Publicado: (2023)

Antiepileptogenesis and disease modification: Progress, challenges, and the path forward—Report of the Preclinical Working Group of the 2018 NINDS‐sponsored antiepileptogenesis and disease modification workshop
por: Galanopoulou, Aristea S., et al.
Publicado: (2021)

Comorbid epilepsy and depression—pharmacokinetic and pharmacodynamic drug interactions
por: Miziak, Barbara, et al.
Publicado: (2022)

Development of an antiepileptogenesis drug screening platform: Effects of everolimus and phenobarbital
por: Barker‐Haliski, Melissa, et al.
Publicado: (2021)

Antiepileptogenesis after stroke—trials and tribulations: Methodological challenges and recruitment results of a Phase II study with eslicarbazepine acetate
por: Koepp, Matthias J., et al.
Publicado: (2023)

Efficacy, safety, and potential of extended-release lamotrigine in the treatment of epileptic patients
por: Błaszczyk, Barbara, et al.
Publicado: (2010)

Chemical meningitis in children as a risk factor following craniopharyngioma resection – a case report
por: Chrościńska-Krawczyk, Magdalena, et al.
Publicado: (2020)

C-11, a New Antiepileptic Drug Candidate: Evaluation of the Physicochemical Properties and Impact on the Protective Action of Selected Antiepileptic Drugs in the Mouse Maximal Electroshock-Induced Seizure Model
por: Zagaja, Mirosław, et al.
Publicado: (2021)

Molecular Hydrogen Neuroprotection in Post-Ischemic Neurodegeneration in the Form of Alzheimer’s Disease Proteinopathy: Underlying Mechanisms and Potential for Clinical Implementation—Fantasy or Reality?
por: Pluta, Ryszard, et al.
Publicado: (2022)

Oxidative Stress and Neurodegeneration in Animal Models of Seizures and Epilepsy
por: Łukawski, Krzysztof, et al.
Publicado: (2023)

Clinical utility of adjunctive retigabine in partial onset seizures in adults
por: Rejdak, Konrad, et al.
Publicado: (2012)

Role of oxidative stress in epileptogenesis and potential implications for therapy
por: Borowicz-Reutt, Kinga K., et al.
Publicado: (2020)

The Role of Gut Microbiota in an Ischemic Stroke
por: Pluta, Ryszard, et al.
Publicado: (2021)

Myricetin as a Promising Molecule for the Treatment of Post-Ischemic Brain Neurodegeneration
por: Pluta, Ryszard, et al.
Publicado: (2021)

Neuroinflammation in Post-Ischemic Neurodegeneration of the Brain: Friend, Foe, or Both?
por: Pluta, Ryszard, et al.
Publicado: (2021)

Post-Ischemic Neurodegeneration of the Hippocampus Resembling Alzheimer’s Disease Proteinopathy
por: Pluta, Ryszard, et al.
Publicado: (2021)

The Role of the JAK/STAT Signaling Pathway in the Pathogenesis of Alzheimer’s Disease: New Potential Treatment Target
por: Rusek, Marta, et al.
Publicado: (2023)

Neuroprotective and Neurological/Cognitive Enhancement Effects of Curcumin after Brain Ischemia Injury with Alzheimer’s Disease Phenotype
por: Pluta, Ryszard, et al.
Publicado: (2018)

The Many Faces of Post-Ischemic Tau Protein in Brain Neurodegeneration of the Alzheimer’s Disease Type
por: Pluta, Ryszard, et al.
Publicado: (2021)

Influence of sildenafil on the anticonvulsant action of selected antiepileptic drugs against pentylenetetrazole-induced clonic seizures in mice
por: Nieoczym, Dorota, et al.
Publicado: (2012)

Ketogenic Diet in Alzheimer’s Disease
por: Rusek, Marta, et al.
Publicado: (2019)

Tau Protein Dysfunction after Brain Ischemia
por: Pluta, Ryszard, et al.
Publicado: (2018)

Participation of Amyloid and Tau Protein in Neuronal Death and Neurodegeneration after Brain Ischemia
por: Pluta, Ryszard, et al.
Publicado: (2020)

Gut microbiota and pro/prebiotics in Alzheimer’s disease
por: Pluta, Ryszard, et al.
Publicado: (2020)

Substantiation for the Use of Curcumin during the Development of Neurodegeneration after Brain Ischemia
por: Ułamek-Kozioł, Marzena, et al.
Publicado: (2020)

Ketogenic Diet and Epilepsy
por: Ułamek-Kozioł, Marzena, et al.
Publicado: (2019)

Shared Genomic and Proteomic Contribution of Amyloid and Tau Protein Characteristic of Alzheimer’s Disease to Brain Ischemia
por: Pluta, Ryszard, et al.
Publicado: (2020)

Post-Ischemic Brain Neurodegeneration in the Form of Alzheimer’s Disease Proteinopathy: Possible Therapeutic Role of Curcumin
por: Pluta, Ryszard, et al.
Publicado: (2022)

Participation of Amyloid and Tau Protein in Post-Ischemic Neurodegeneration of the Hippocampus of a Nature Identical to Alzheimer’s Disease
por: Pluta, Ryszard, et al.
Publicado: (2021)

Cross-Talk between Amyloid, Tau Protein and Free Radicals in Post-Ischemic Brain Neurodegeneration in the Form of Alzheimer’s Disease Proteinopathy
por: Pluta, Ryszard, et al.
Publicado: (2022)

Neuroprotective Actions of Neurosteroids
por: Borowicz, Kinga K., et al.
Publicado: (2011)

Proteomic and Genomic Changes in Tau Protein, Which Are Associated with Alzheimer’s Disease after Ischemia-Reperfusion Brain Injury
por: Ułamek-Kozioł, Marzena, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0cc21d2pe38fgmm3sna0rb88si